These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 478263)

  • 1. [Determination of the plasma ribonuclease activity as a diagnostic aid in the diagnosis of ovarian cancer. Results of a double blind study (author's transl)].
    Wolf A; Vahrson H; Hoss M
    Geburtshilfe Frauenheilkd; 1979 Jun; 39(6):497-502. PubMed ID: 478263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Serum ribonuclease activity in patients with gynaecologic malignomas (author's transl)].
    Schleich HG; Wiest W
    Geburtshilfe Frauenheilkd; 1979 Nov; 39(11):940-6. PubMed ID: 510896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Serum ribonuclease activity in gynecologic neoplasms. The behavior of serum ribonuclease in ovarian cancer under cytostatic therapy].
    Schleich HG; Wiest W
    Fortschr Med; 1980 Sep; 98(36):1384-6. PubMed ID: 7461546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble urokinase plasminogen activator receptor in preoperatively obtained plasma from patients with gynecological cancer or benign gynecological diseases.
    Riisbro R; Stephens RW; Brünner N; Christensen IJ; Nielsen HJ; Heilmann L; von Tempelhoff GF
    Gynecol Oncol; 2001 Sep; 82(3):523-31. PubMed ID: 11520150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Alterations of the plasma ribonuclease activity in female wistar rats under the conditions of combined therapy of the ovary carcinoma (author's transl)].
    Wolf A; Hoss M; Vahrson H
    Strahlentherapie; 1979 Dec; 155(12):864-8. PubMed ID: 316209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic markers for early detection of ovarian cancer.
    Visintin I; Feng Z; Longton G; Ward DC; Alvero AB; Lai Y; Tenthorey J; Leiser A; Flores-Saaib R; Yu H; Azori M; Rutherford T; Schwartz PE; Mor G
    Clin Cancer Res; 2008 Feb; 14(4):1065-72. PubMed ID: 18258665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Serum ribonuclease in patients with malignant tumor of the ovary].
    Liu SS; Cai GR
    Zhonghua Fu Chan Ke Za Zhi; 1991 Jan; 26(1):17-20, 61. PubMed ID: 2004569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Changes of plasma ribonuclease activities according to the method of treatment in gynecologic cancer patients (author's transl)].
    Sugawara S
    Nihon Sanka Fujinka Gakkai Zasshi; 1981 Oct; 33(10):1749-56. PubMed ID: 7310199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic studies of early-stage and advanced ovarian cancer patients.
    Wang J; Zhang X; Ge X; Guo H; Xiong G; Zhu Y
    Gynecol Oncol; 2008 Oct; 111(1):111-9. PubMed ID: 18703221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of cancer in patients by reduced lymphocytic cortisol metabolism-enhancing effect.
    Klein A; Kaufman H; Arie R; Hoogervorst-Spalter H; Semach E; Barkan A; Martfel J; Servadio C
    J Natl Cancer Inst; 1980 Nov; 65(5):857-61. PubMed ID: 6933254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Plasma"-type ribonuclease in pancreatic cancer diagnosis: a critical appraisal.
    Fabris C; Farini R; del Favero G; Piccoli A; Naccarato R
    Hepatogastroenterology; 1981 Dec; 28(6):316-8. PubMed ID: 7345012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum endostatin levels in patients with epithelial ovarian cancer.
    Hata K; Dhar DK; Kanasaki H; Nakayama K; Fujiwaki R; Katabuchi H; Okamura H; Nagasue N; Miyazaki K
    Anticancer Res; 2003; 23(2C):1907-12. PubMed ID: 12820477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnostic values of serum ribonuclease activities in pancreatic carcinoma (author's transl)].
    Igarashi F; Nakayama T; Kitamura M; Takeuchi K
    Rinsho Byori; 1980 Nov; 28(11):1141-4. PubMed ID: 7241817
    [No Abstract]   [Full Text] [Related]  

  • 14. A comparative study of mucin-like carcinoma-associated antigen (MCA), CA 125, CA 19-9 and CEA in patients with ovarian cancer.
    Koelbl H; Schieder K; Neunteufel W; Bieglmayer C
    Neoplasma; 1989; 36(4):473-8. PubMed ID: 2770933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The utility of positron emission tomography for the diagnosis and staging of recurrent esophageal cancer.
    Flamen P; Lerut A; Van Cutsem E; Cambier JP; Maes A; De Wever W; Peeters M; De Leyn P; Van Raemdonck D; Mortelmans L
    J Thorac Cardiovasc Surg; 2000 Dec; 120(6):1085-92. PubMed ID: 11088030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarker discovery for ovarian cancer using SELDI-TOF-MS.
    Zhang H; Kong B; Qu X; Jia L; Deng B; Yang Q
    Gynecol Oncol; 2006 Jul; 102(1):61-6. PubMed ID: 16403569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of telomerase activity in ovarian cystadenomas, low-malignant-potential tumors, and invasive carcinomas.
    Datar RH; Naritoku WY; Li P; Tsao-Wei D; Groshen S; Taylor CR; Imam SA
    Gynecol Oncol; 1999 Sep; 74(3):338-45. PubMed ID: 10479490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Serum ribonuclease activity in the diagnosis of malignant neoplasms (author's transl)].
    Akagi K; Murai K; Tsuji H; Shikata T; Omae T; Yamanaka M
    Nihon Naika Gakkai Zasshi; 1982 Jan; 71(1):37-42. PubMed ID: 7086248
    [No Abstract]   [Full Text] [Related]  

  • 19. Proteomics and cancer: running before we can walk?
    Check E
    Nature; 2004 Jun; 429(6991):496-7. PubMed ID: 15175721
    [No Abstract]   [Full Text] [Related]  

  • 20. Afamin and apolipoprotein A-IV: novel protein markers for ovarian cancer.
    Dieplinger H; Ankerst DP; Burges A; Lenhard M; Lingenhel A; Fineder L; Buchner H; Stieber P
    Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1127-33. PubMed ID: 19336561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.